Thoratec Corp (NASDAQ:THOR)
| CAPS Rating |
|
|---|---|
| Open | $34.13 |
| Previous Close | $34.52 |
| Daily Range | $33.55 - $34.53 |
| 52-Week Range | $24.75 - $38.07 |
| Market Cap | $2.04B |
| P/E Ratio | 32.60 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,066,952 |
| Average Daily Volume | 0 |
THOR
VS S&P 500 (SPY)
How do you think THOR will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
THOR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
THOR News and Commentary
- Thoratec Beats Up on Analysts Yet Again – The Motley Fool
- Outperform on Abiomed - Analyst Blog – NASDAQ
- Thoratec Beats, Profit Jumps - Analyst Blog – NASDAQ
- Thoratec Shares Popped: What You Need to Know – The Motley Fool
- Abiomed Tops, Swings to Black - Analyst Blog – NASDAQ
- Thoratec Earnings Preview – The Motley Fool
- 1 Great Dividend You Can Buy Right Now – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Abiomed's Analyst Day Excerpts - Analyst Blog – NASDAQ
- Are Thoratec's Earnings Worse Than They Look? – The Motley Fool
- 1 Reason Thoratec May Be Headed for a Slowdown – The Motley Fool
- Positive USpella Data from Abiomed - Analyst Blog – NASDAQ
- Thoratec Shares Plunged: What You Need to Know – The Motley Fool
- Biotech M&A: Analyst Gives 5 Potential Targets in Biomedical Devices – NASDAQ
- Biotech M&A: Analyst Gives 5 Potential Targets in Biomedical Devices – The Motley Fool
- The 9 Top Value-Creating Medical Device Companies – The Motley Fool
- Don't Get Too Worked Up Over Thoratec's Latest Numbers – The Motley Fool
- Thoratec's CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- UPDATE: Thoratec CFO Smith Resigns; Finance VP Named Interim CFO – SmartMoney
RSS Headlines
Fool UK
